about
Anti-CD38 autoantibodies in type? diabetesDaratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myelomaMonoclonal antibodies targeting CD38 in hematological malignancies and beyondAcidic residues at the active sites of CD38 and ADP-ribosyl cyclase determine nicotinic acid adenine dinucleotide phosphate (NAADP) synthesis and hydrolysis activitiesFunctional and prognostic role of ZAP-70 in chronic lymphocytic leukaemiaEvolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathologyMolecular cloning and functional expression of bovine spleen ecto-NAD+ glycohydrolase: structural identity with human CD38Inhibition of the intrinsic NAD+ glycohydrolase activity of CD38 by carbocyclic NAD analoguesIdentification and functional characterization of the hepatic stellate cell CD38 cell surface moleculeTransfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblastsCharacterization of a novel human surface molecule selectively expressed by mature thymocytes, activated T cells and subsets of T cell lymphomas.Spatial and temporal mapping of c-kit and its ligand, stem cell factor expression during human embryonic haemopoiesis.CD38 ligation induces tyrosine phosphorylation of Bruton tyrosine kinase and enhanced expression of interleukin 5-receptor alpha chain: synergistic effects with interleukin 5.Analysis of the human thymic perivascular space during agingThe MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes.CD157, the Janus of CD38 but with a unique personality.CD38 expressed on human monocytes: a coaccessory molecule in the superantigen-induced proliferation.The prognostic value of CD38 expression and its quantification in B cell chronic lymphocytic leukemia (B-CLL).CD38 autoimmunity: recent advances and relevance to human diabetes.Ligation of CD38 suppresses human B lymphopoiesis.A critical role of Lyn and Fyn for B cell responses to CD38 ligation and interleukin 5The CD38/CD157 mammalian gene family: An evolutionary paradigm for other leukocyte surface enzymes.Characterization of a CD38-like 78-kilodalton soluble protein released from B cell lines derived from patients with X-linked agammaglobulinemia.Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists.Review: NAD +: a modulator of immune functions.Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity.Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma.Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody.Effect of CD38 on the multidrug resistance of human chronic myelogenous leukemia K562 cells to doxorubicin.T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB).The multi-faceted potential of CD38 antibody targeting in multiple myeloma.The membrane-bound enzyme CD38 exists in two opposing orientations.Treatment options for relapse after autograft in multiple myeloma - report from an EBMT educational meeting.Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo.Sphingolipid microdomains mediate CD38 internalization: topography of the endocytosis.CD38 is associated with lipid rafts and upon receptor stimulation leads to Akt/protein kinase B and Erk activation in the absence of the CD3-zeta immune receptor tyrosine-based activation motifs.Clinical ineffectiveness of IL-2 and/or IFN alpha administration after autologous PBSC transplantation in pediatric oncological patients.The CD3-gamma delta epsilon transducing module mediates CD38-induced protein-tyrosine kinase and mitogen-activated protein kinase activation in Jurkat T cells.All-trans retinoic acid (ATRA) and the regulation of adhesion molecules in acute myeloid leukemia.CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK/T cell lymphoma, nasal type.
P2860
Q24652207-07100C7E-6EC0-4055-BB36-84AF269734E8Q26745919-EE18C61C-3DD5-47D4-87DC-870AE8390A78Q26766718-014803E7-B657-4197-9765-2E64C7D453B9Q28253562-75557B01-EC74-4BB9-9CF5-D8C0158A057CQ28282822-1FF27F1F-D510-4C63-B73D-749700B82C26Q28287124-538D8C6E-E53D-4C18-971C-73C064F88B13Q28343793-9C2939B5-7E0D-4DF6-8634-8D47B0B0292CQ28369136-0B30C944-2538-4B6F-8057-F61BDDC21A13Q28573700-139BD298-0B19-4136-BB43-3067EB4DFEA1Q30442862-E9C235EC-7BD9-4C61-BD46-4D1ED4995E86Q31406838-C617662C-421F-4AFA-B846-EAD720231707Q33179241-203F4AC4-E217-4F50-8F0A-9004C020E8F6Q33725816-7FC3B7A6-EDD3-4E62-9375-98986997BC24Q33859403-38A101C5-912F-4DA0-B87B-6C6327E28AA1Q33878809-8FB9B904-4F1C-407F-866D-DBA31B6BC7C0Q34157703-E5E8BBC9-9E44-4000-BAD6-D3306A2A37F9Q35082430-0C83C39E-15D6-4A4E-B326-8A5B916CB90EQ35782533-F7887949-76E0-4E12-8402-3D5434EA4E0CQ35928098-9DA7D493-989A-40C0-81F7-FBC7748218ABQ36364524-952E46F8-1D16-4F2F-920F-B5EB342D69A2Q36585953-BE112C43-51E9-4E4D-9FEC-E9035BF34AC4Q37135558-AC4561A4-9D07-4C46-AE01-8223B44F7661Q37383714-16064FBB-F3CE-460A-B492-175386F157D0Q37728235-AF3AC924-4374-42C6-B957-3757664366EEQ37730290-1EAA4663-0521-4D23-AAE2-D08E2A917671Q37876541-CE14B653-2E12-4FE3-9462-7C0C073B3F84Q38090691-19B8F237-430B-4896-A94C-88010D92258AQ38298476-709B7C4A-F03F-4D24-9399-5BF0344C855CQ38721759-F9B8967D-1D9D-4F8D-AC68-351474387104Q38885631-E12CEEA8-9E18-400D-B451-7B943BA3D7CFQ39200031-51645D1E-B778-49AD-8FF0-CA6C07F28334Q39280765-BE3A3068-64C2-4918-AE11-7F15B499FEA8Q39369772-0DBFE2C3-96A5-45EC-9017-1AC0942259DCQ39588498-249E115E-E075-49CA-8D40-7BE8FBF39546Q40508591-DEB10FD2-BF91-466A-8527-018BE689935AQ40771031-03CC4AC8-8425-4749-AE2A-C027F05A58B7Q40898117-0FE2B343-F071-4136-A61F-DA0402604045Q40942972-1E1400EF-F78D-4A20-BDDE-631BC0963C6EQ41049801-3BCFE206-B4C3-44E3-8A39-7978CEC23DEEQ41085075-5B84A574-912A-4A39-8BE7-A31BB80CA108
P2860
description
1994 nî lūn-bûn
@nan
1994 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մարտին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Human CD38: a glycoprotein in search of a function
@ast
Human CD38: a glycoprotein in search of a function
@en
Human CD38: a glycoprotein in search of a function
@nl
type
label
Human CD38: a glycoprotein in search of a function
@ast
Human CD38: a glycoprotein in search of a function
@en
Human CD38: a glycoprotein in search of a function
@nl
prefLabel
Human CD38: a glycoprotein in search of a function
@ast
Human CD38: a glycoprotein in search of a function
@en
Human CD38: a glycoprotein in search of a function
@nl
P2093
P3181
P1433
P1476
Human CD38: a glycoprotein in search of a function
@en
P2093
P3181
P356
10.1016/0167-5699(94)90148-1
P407
P577
1994-03-01T00:00:00Z